Stay tuned and follow the latest
developments and news in Molecular Oncology.
Genekor participated in the San Antonio Breast Cancer Symposium (#SABCS), held on December 9–12, 2025 in Texas, one of the leading international scientific congresses dedicated to breast cancer research and clinical management. During […]
Read More
ADEA Lab, a diagnostic laboratory specialized in precision medicine, and Genekor Medical S.A., a leader in molecular diagnostics, are pleased to announce a strategic alliance focused on delivering cutting-edge precision […]
Read More
Genekor attended the 11th Hellenic Congress of the Breast Surgery (EXEM), held in Athens from 14 to 16 November 2025 at the Royal Olympic Hotel, contributing to the scientific dialogue on current developments in breast […]
Read More
Genekor Medical S.A., in collaboration with Women for Oncology – W4O Hellas, announces its participation in the initiative “Genetic Testing for Breast Cancer” (Participation Code: GEN-BC25). As part of this initiative, up […]
Read More
Genekor Medical S.A. has been accredited to the ISO 15189:2022 standard for both of its laboratories, in Athens and Thessaloniki. This international standard is specifically designed for medical laboratories and […]
Read More
Following the presentation of the ALASCCA trial at ASCO GI 2025, aspirin has emerged as a promising adjuvant therapy in patients with stage II–III colorectal cancer (CRC) harboring PI3K pathway alterations […]
Read More
We are pleased to share the latest publication featuring Prime DX in the International Journal of Molecular Sciences “Comprehensive Evaluation of a 1021-Gene Panel in FFPE and Liquid Biopsy for Analytical and Clinical Use” […]
Read More
ASCO 2025 Genekor’s Online Publications Genekor is excited to invite you to go through our 7 online publications at this year’s ASCO meeting in May 30 – June 3, 2025, Chicago, Illinois. […]
Read More
The scientific team of GeneKor had a strong presence at the 31st Hellenic Congress of Clinical Oncology, held in Athens from April 9–12, 2025. Our team participated with 10 scientific […]
Read More